Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Greenwich LifeSciences, Inc. (GLSI) had Free Cash Flow per Share of $-0.45 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.95M |
|
-- |
|
-- |
|
$4.02M |
|
$-4.02M |
|
$0.07M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-4.02M |
|
$-4.02M |
|
14.62M |
|
14.62M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$8.88M |
|
-- |
|
-- |
|
$8.88M |
|
$5.76M |
|
-- |
|
-- |
|
$5.76M |
|
$3.12M |
|
$3.12M |
|
$3.12M |
|
14.68M |
|
| Cash Flow Statement Financials | |
$-6.64M |
|
-- |
|
$9.34M |
|
$6.18M |
|
$8.88M |
|
$2.70M |
|
$3.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-126.68% |
|
-126.68% |
|
-44.49% |
|
-126.68% |
|
$0.21 |
|
|
Free Cash Flow per Share |
$-0.45 |
$-0.45 |
|